✦ LIBER ✦

Effects of atropine on human cardiac β1- and/ or β2-adrenoceptor stimulation

✍ Scribed by Heike Bruck; Anke Ulrich; Stefan Gerlach; Joachim Radke; Otto-Erich Brodde

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 221 KB
Volume: 367
Category: Article
ISSN: 0028-1298
DOI: 10.1007/s00210-003-0757-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of verapamil withdrawal on cardia

Effect of verapamil withdrawal on cardiac β1-adrenoceptor density

✍ W. G. Nayler; J. S. Dillon 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 399 KB

Effect of verapamil withdrawal on cardia

Effect of verapamil withdrawal on cardiac β1-adrenoceptor density

✍ W. G. Nayler; J. S. Dillon 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 434 KB

Electrophysiological effects mediated by

Electrophysiological effects mediated by the stimulation of cardiac β2-adrenoceptors with tulobuterol

✍ Alessandro Mugelli; Sandra Amerini; Paolo Bonfioli Cavalcabo; Elisabetta Cerbai; 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 541 KB

Cardiostimulant and cardiodepressant eff

Cardiostimulant and cardiodepressant effects through overexpressed human β2-adrenoceptors in murine heart: regional differences and functional role of β1-adrenoceptors

✍ Jürgen F. Heubach; Marianne Blaschke; Sian E. Harding; Ursula Ravens; Alberto J. 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 323 KB

α1- and β-adrenoceptor stimulation poten

α1- and β-adrenoceptor stimulation potentiate the anticonflict effect of a benzodiazepine

✍ B. Söderpalm; J. A. Engel 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 850 KB

The effects of chronic dosing on the β1a

The effects of chronic dosing on the β1and β2-adrenoceptor antagonism of betaxolol and atenolol

✍ B. J. Lipworth; N. A. Irvine; D. G. McDevitt 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 508 KB

Six normal subjects were given once daily treatment for 15 days with placebo (PL), betaxolol 10 mg (B10), 40 mg (B40); atenolol 100 mg (A 100); and nadolol 40 mg (N40). Measurements of beta 1-adrenoceptorblockade (reduction of exercise heart rate) and of beta 2-adrenoceptor-blockade (attenuation of